# Rapivab

NDC: 72769-181
Generic name: peramivir
Labeler / Manufacturer: BioCryst Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION
Routes: INTRAVENOUS
Marketing started: 20141220

FDA application: NDA206426

## Active ingredients

- PERAMIVIR: 600 mg/60mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72769-181"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72769-181
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fe04f6cd-e71c-4bd4-abac-97720bba2a0d